0001140361-16-067949.txt : 20160531
0001140361-16-067949.hdr.sgml : 20160531
20160531185217
ACCESSION NUMBER: 0001140361-16-067949
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160526
FILED AS OF DATE: 20160531
DATE AS OF CHANGE: 20160531
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC
CENTRAL INDEX KEY: 0001048477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680397820
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 4155066700
MAIL ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FUCHS HENRY J
CENTRAL INDEX KEY: 0001197355
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26727
FILM NUMBER: 161687459
MAIL ADDRESS:
STREET 1: C/O INTRABIOTICS PHARMACEUTICALS INC
STREET 2: 1245 TERRA BELLA AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
4
1
doc1.xml
FORM 4
X0306
4
2016-05-26
0
0001048477
BIOMARIN PHARMACEUTICAL INC
BMRN
0001197355
FUCHS HENRY J
C/O BIOMARIN PHARMACEUTICAL INC.
770 LINDARO ST.
SAN RAFAEL
CA
94901
0
1
0
0
EVP, Chief Medical Officer
Common Stock
2016-05-26
2016-05-26
4
M
0
15000
26.49
A
130914
D
Common Stock
2016-05-26
2016-05-26
4
S
0
10000
88.04
D
120914
D
Common Stock
2016-05-26
2016-05-26
4
S
0
5000
87.34
D
115914
D
Common Stock (Right to buy Common Stock)
26.49
2016-05-26
2016-05-26
4
M
0
15000
0
D
2011-11-12
2021-05-11
Common Stock
15000
65225
D
All shares were sold at the same price
The price in column 4 is a weighed average price. The price actually received ranged from $86.50 to $88.34. The reporting person will provide to the issuer, and security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Reflects the number of stock options outstanding after the transaction from this specific stock option grant.
/s/ Laura Randall Woodhead, Attorney-in-Fact
2016-05-31